Search the Newsreel

LiveRamp (NYSE: RAMP) expands Publicis merger analysis with $38.50 per share terms

LiveRamp Holdings, Inc. has provided additional details regarding its pending acquisition by Publicis Groupe S.A. for $38.50 per share in cash. The company expanded on the background of the merger, including efforts to retain key management and Evercore’s valuation analyses (discounted cash flow, trading, …

Investing in Monster Beverage (MNST)? Don't Miss Assessing Its International Revenue Trends

Have you evaluated the performance of Monster Beverage's (MNST) international operations for the quarter ending June 2026? Given the extensive global presence of this energy drink maker, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth. …

The Energy Drink Buyout Prize Beverage Giants Are Circling

Quick Read Celsius Holdings (CELH) trades at a ~$7 billion market cap after falling 39% this year, yet commands roughly 20% of the U.S. energy drink market. PepsiCo (PEP) already distributes Celsius and holds an 11% equity stake from a $585 million investment, making …

Price-Driven Insight from (FIZZ) for Rule-Based Strategy

This article provides a price-driven insight for National Beverage Corp. (NASDAQ: FIZZ) based on AI models, highlighting a positive near-term sentiment that may shift and a mid-channel oscillation pattern. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, …

Veraxa Biotech Holding AG SEC Filing (Aug 10, 2026)

Veraxa Biotech Holding AG (NASDAQ: VRXA) announced the effectiveness of its F-1 filing with the SEC, dated August 6, 2026, at 4:00 P.M. The filing indicates a neutral impact and sentiment, as analyzed by StockTitan's AI. This notice of effectiveness relates to the company's …

Vera Therapeutics (VERA) Earnings Date and Reports 2026

Monster Beverage (MNST) Podría Cotizar Un 53% Por Debajo De Su Valor Razonable Mientras Crecen Sus Ventas Internacionales

TAP Q2 Deep Dive: Margin Pressures Persist as Molson Coors Leans on Brand and Portfolio Initiatives

TAP Q2 Deep Dive: Margin Pressures Persist as Molson Coors Leans on Brand and Portfolio Initiatives Beer company Molson Coors (NYSE:TAP) met Wall Street's revenue expectations in Q2 CY2026, but sales fell by 3.3% year on year to $3.10 billion. Its non-GAAP profit of …

National Beverage Corp. Actuals & Estimates (NASDAQ:FIZZ)

This article provides an overview of National Beverage Corp. (NASDAQ: FIZZ) stock, including its current price, historical performance, analyst forecasts, and key financial metrics. It details earnings, revenue, market capitalization, and dividend information, offering insights into the company's financial health and market position.

Warum Monster Beverage (MNST) nach einem starken Ergebnis im ersten Halbjahr 2026 um 6,2 % nachgibt – und wie es weitergeht

Why Monster Beverage (MNST) Is Down 6.2% After Stronger First-Half 2026 Earnings Performance And What's Next

Monster Beverage Corp (MNST) reported a strong Q2 2026, surpassing analyst expectations with EPS of $0.60 against an estimated $0.58, and revenue of $2.54 billion compared to an estimated $2.43 billion. The company's international sales significantly contributed to this performance, now accounting for 46% …

Por qué Monster Beverage (MNST) ha caído un 6,2 % tras unos sólidos resultados del primer semestre de 2026 y qué se prevé para el futuro

Did Veralto’s (VLTO) Q2 Buybacks and Alfaa UV Deal Just Reframe Its Capital Playbook?

Veralto Corporation reported strong Q2 2026 results with higher sales and net income, alongside a significant share repurchase program and the acquisition of Alfaa UV. The company emphasizes M&A, particularly bolt-on acquisitions in water treatment, as its primary capital allocation strategy, aiming to strengthen …

Monster Beverage (NASDAQ:MNST) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Monster Beverage (NASDAQ:MNST) reported strong quarterly earnings, surpassing analyst expectations with an EPS of $0.60 against a $0.58 consensus and revenue of $2.50 billion, a 20.2% increase year-over-year. The growth was driven by broad-based international expansion and increased U.S. market share for its Ultra …

Liveramp Holdings Inc (RAMP) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for LiveRamp Holdings Inc (RAMP), highlighting its current earnings forecast score, average price target, and analyst ratings. It also includes expected revenue for the next quarter, historical EPS performance, and the consensus analyst rating.

Vera Bradley Inc (VRA) Stock News Today

This article provides a brief update on Vera Bradley Inc (VRA) stock news. It notes the current stock price and market capitalization, stating that more news, earnings, analyst ratings, and key developments will be available soon. The content indicates that updates are pending.

Vera Bradley Inc (VRA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Vera Bradley Inc (VRA), detailing its current earnings forecast score, average price target of $5.50, and analyst ratings. Based on one analyst, the stock holds a "Hold" signal, with an expected revenue of $65.95M for the next …

State Street Corporation (VSTM) discloses 5.8% beneficial ownership in INC common stock

State Street Corporation has disclosed a 5.8% beneficial ownership stake in Verastem Inc. (VSTM) common stock through a SCHEDULE 13G filing. This represents 5,133,859 shares held with shared voting and dispositive power through its investment management subsidiaries. The filing indicates a neutral sentiment and …

VERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform

VERAXA Biotech is making significant strides in antibody therapeutics with its proprietary BiTAC platform, focusing on bispecific ADCs and T-cell engagers. The company's platform is designed for precision and efficacy, positioning it for potential partnerships and licensing deals in the rapidly growing market for …

A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $12 to $18

This article provides a quick overview of recent analyst ratings for Verastem (VSTM.US), highlighting that analysts have set price targets ranging from $12 to $18. The information suggests a positive outlook for the company's stock from the perspective of financial analysts.

Molson Coors (TAP) Stock Rally Faces Margin Pressure And Losses

Innovation Beverage Group Ltd (IBG) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Innovation Beverage Group Ltd (IBG), detailing its current stock price, market capitalization, and analyst ratings. Based on zero analysts, the target price is USD 4.00, representing a potential upside of +566.44%. The article highlights a lack of …

Verastem (VSTM) Stock Rallies On Revenue Surge And Pipeline Pressure

Verastem, Inc. Stock 12‑Month Price Target Cut to $14.88, Implies 152% Upside

Verastem, Inc.'s average price target has been lowered from $15 to $14.88 by 8 analysts, with individual forecasts ranging from $9 to $18 per share. This updated target suggests a potential upside of approximately 152% from its Aug. 6 closing price. The consensus rating …

Molson Coors Beverage (NYSE:TAP) Posts Earnings Results, Beats Estimates By $0.07 EPS

Verastem Inc (VSTM) Stock News Today

This article from TradingKey provides current stock information for Verastem Inc (VSTM), noting a 14.04% increase in its stock price to $6.740. It offers an overview of the company's market cap and indicates that more news, earnings, analyst ratings, and key developments will be …

Verastem (NASDAQ:VSTM) Posts Earnings Results, Beats Estimates By $0.08 EPS

Monster Beverage (MNST) Stock Sinks As Record Sales Meet Premium Doubts

Verastem Amends Oberland Financing, Adding Up to $75 Million Revenue-Share Notes Maturing 2033

Verastem has amended its financing agreement with Oberland Capital-managed funds and RGCM SA to introduce up to $75 million in new revenue-backed senior secured notes, maturing in 2033. The new notes include an initial $50 million tranche available by August 28, 2026, and an …

Veracyte, Inc. $VCYT Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC reduced its stake in Veracyte, Inc. (NASDAQ:VCYT) by 31% in the first quarter, selling 84,255 shares but still retaining 187,368 shares valued at approximately $6 million. Despite this sale, analyst sentiment remains largely positive with a "Moderate Buy" rating and …

State Street Corporation (VERA) discloses 4.1M-share stake in Vera Therapeutics

State Street Corporation has reported a beneficial ownership of 4,148,786 shares of Vera Therapeutics Inc. common stock, which represents a 5.8% stake in the company. The filing indicates that State Street holds shared voting power over 3,996,044 shares and shared dispositive power over all …

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics announced inducement grants of non-qualified stock options and restricted stock units (RSUs) to new employees, including its new Chief Regulatory Officer, Nancy Bowman, M.D., Ph.D. These grants, made under the company's 2024 Inducement Plan, are consistent with Nasdaq Listing Rule 5635(c)(4) and …

LiveRamp (RAMP) Stock Faces Deal Ceiling Despite Margin Reset

LiveRamp (RAMP) reported strong Q1 2027 earnings, with increased revenue, net income, and EPS, alongside a significant improvement in net margin to 18.6%. Despite these positive operational results and a valuation analysis suggesting a genuine discount, the stock's muted reaction and nearly flat performance …

Royal Bank of Canada Grows Stock Holdings in Veracyte, Inc. $VCYT

Royal Bank of Canada increased its stake in Veracyte, Inc. (NASDAQ:VCYT) by 66.4% in the first quarter, acquiring an additional 228,720 shares, bringing its total to 573,096 shares valued at approximately $18.46 million. This move is part of a broader trend of institutional investors …

Monster Beverage (NASDAQ:MNST) Price Target Raised to $101.00

Piper Sandler has increased its price target for Monster Beverage (NASDAQ:MNST) to $101.00 from $94.00, maintaining an "overweight" rating. This adjustment comes after Monster Beverage exceeded quarterly expectations with $0.60 EPS and $2.50 billion in revenue, reflecting 20.2% year-over-year growth driven by international demand. …

Molson Coors Q2 Earnings Beat Estimates on Pricing and Cost Savings